» Articles » PMID: 25279699

The Glucuronyltransferase B4GAT1 is Required for Initiation of LARGE-mediated α-dystroglycan Functional Glycosylation

Overview
Journal Elife
Specialty Biology
Date 2014 Oct 4
PMID 25279699
Citations 60
Authors
Affiliations
Soon will be listed here.
Abstract

Dystroglycan is a cell membrane receptor that organizes the basement membrane by binding ligands in the extracellular matrix. Proper glycosylation of the α-dystroglycan (α-DG) subunit is essential for these activities, and lack thereof results in neuromuscular disease. Currently, neither the glycan synthesis pathway nor the roles of many known or putative glycosyltransferases that are essential for this process are well understood. Here we show that FKRP, FKTN, TMEM5 and B4GAT1 (formerly known as B3GNT1) localize to the Golgi and contribute to the O-mannosyl post-phosphorylation modification of α-DG. Moreover, we assigned B4GAT1 a function as a xylose β1,4-glucuronyltransferase. Nuclear magnetic resonance studies confirmed that a glucuronic acid β1,4-xylose disaccharide synthesized by B4GAT1 acts as an acceptor primer that can be elongated by LARGE with the ligand-binding heteropolysaccharide. Our findings greatly broaden the understanding of α-DG glycosylation and provide mechanistic insight into why mutations in B4GAT1 disrupt dystroglycan function and cause disease.

Citing Articles

Long-term CSF responses in adult patients with spinal muscular atrophy type 2 or 3 on treatment with nusinersen.

Cebulla G, Hai L, Warnken U, Gungor C, Hoffmann D, Korporal-Kuhnke M J Neurol. 2025; 272(4):270.

PMID: 40085221 DOI: 10.1007/s00415-025-12984-7.


Ribitol and ribose treatments differentially affect metabolism of muscle tissue in FKRP mutant mice.

Cataldi M, Lu Q Sci Rep. 2025; 15(1):1329.

PMID: 39779805 PMC: 11711661. DOI: 10.1038/s41598-024-83661-4.


Saturation mutagenesis-reinforced functional assays for disease-related genes.

Ma K, Huang S, Ng K, Lake N, Joseph S, Xu J Cell. 2024; 187(23):6707-6724.e22.

PMID: 39326416 PMC: 11568926. DOI: 10.1016/j.cell.2024.08.047.


Dystroglycan-HSPG interactions provide synaptic plasticity and specificity.

Melrose J Glycobiology. 2024; 34(10).

PMID: 39223703 PMC: 11368572. DOI: 10.1093/glycob/cwae051.


Molecular signatures of normal pressure hydrocephalus: a large-scale proteomic analysis of cerebrospinal fluid.

Kamalian A, Shirzadeh Barough S, Ho S, Albert M, Luciano M, Yasar S Fluids Barriers CNS. 2024; 21(1):64.

PMID: 39118132 PMC: 11312837. DOI: 10.1186/s12987-024-00561-5.


References
1.
Stanley P . Membrane mutants of animal cells: rapid identification of those with a primary defect in glycosylation. Mol Cell Biol. 1985; 5(5):923-9. PMC: 366806. DOI: 10.1128/mcb.5.5.923-929.1985. View

2.
Barresi R, Campbell K . Dystroglycan: from biosynthesis to pathogenesis of human disease. J Cell Sci. 2006; 119(Pt 2):199-207. DOI: 10.1242/jcs.02814. View

3.
Johnson B, Blevins R . NMR View: A computer program for the visualization and analysis of NMR data. J Biomol NMR. 2012; 4(5):603-14. DOI: 10.1007/BF00404272. View

4.
Ervasti J, Campbell K . Membrane organization of the dystrophin-glycoprotein complex. Cell. 1991; 66(6):1121-31. DOI: 10.1016/0092-8674(91)90035-w. View

5.
Bakker H, Oka T, Ashikov A, Yadav A, Berger M, Rana N . Functional UDP-xylose transport across the endoplasmic reticulum/Golgi membrane in a Chinese hamster ovary cell mutant defective in UDP-xylose Synthase. J Biol Chem. 2008; 284(4):2576-83. PMC: 2629108. DOI: 10.1074/jbc.M804394200. View